MAY 23, 2018 11:44 PM PDT

Isolating The Source of Interleukin-25 In Common Respiratory Disorders

WRITTEN BY: Nouran Amin

The latest discovery from the Perelman School of Medicine at the University of Pennsylvania examined the mechanisms behind how the immune system responds to common sinus infections and asthma attacks.

 

This discovery may explain why affected individuals develop these issues in the first place with hopes to create an effective therapeutic strategy. More specifically, investigators isolated the source of the inflammatory cytokine Interleukin-25 (IL-25), which is an immune molecule that recruits a subset of inflammatory cells. Most commonly diagnosed respiratory disorders, such as chronic rhinosinusitis and asthma, have been tied to elevated levels of IL-25, but the origins remain unknown.

 

Now, the source of IL-25 is believed to be a solitary chemosensory cell (SCC). In tissue samples that are non-inflamed, SCCs compose one percent of human cells lining the sinuses. But, when the researchers examined human nasal polyps, the number of SCCs that lining the polyp tissue have strikingly increased. Furthermore, when these cells were treated with inflammatory molecule Interleukin-13 (IL-13), which has also been involved in driving nasal polyp formation and asthma, it stimulated the expansion of the SCCs and increased the production of IL-25. "The more of these cells are present, the more likely the body will mount an inappropriate, exaggerated immune response due to elevated levels of IL-25. The body ends up in a vicious cycle, and so it never goes back to its baseline," explains the study's senior author Noam A. Cohen, MD, Ph.D., director of Rhinology Research at Penn.

 

Structure of Interleukin-13

The researchers also discovered that IL-25 is not relapsed in tissues, but relapsed in the mucus. This means that IL-25 has to come from the mucus before it reaches the tissue to exert its effects. Otherwise, IL-25 remaining in the mucus site will be excreted out of the body through sneezing. "We can measure levels of IL-25 in the mucus, so it's possible this can be an indicator of who will develop conditions like polyps or asthma," adds the study's lead author Michael Kohanski, MD, Ph.D. "Also, if we can bind up IL-25 before it reaches the tissue, we may be able to prevent the inflammation altogether." SCC's secreting IL-25 is fairly a normal process, and therefore it is not something that can be prevented. "Rather, we want to control the excessive concentrations found in polyps in a targeted way, perhaps with a nasal spray," explains Cohen.

https://b98584f181.site.internapcdn.net/tmpl/v5/img/1x1.gif

Source: Journal of Allergy and Clinical Immunology

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUN 28, 2021
Cell & Molecular Biology
Bringing Light to Extracellular Vesicles
JUN 28, 2021
Bringing Light to Extracellular Vesicles
Though originally thought of as strictly a waste disposal system, extracellular vesicles (EVs) have been shown to have m ...
AUG 05, 2021
Immunology
Nosedive: Poor Nasal Antiviral Responses Linked to Severe COVID
AUG 05, 2021
Nosedive: Poor Nasal Antiviral Responses Linked to Severe COVID
Talking, singing, coughing—all of these can spread COVID-19 from an infected person via respiratory aerosols. Thes ...
AUG 10, 2021
Health & Medicine
Care Managers During COVID-19, A Vital Value-Add
AUG 10, 2021
Care Managers During COVID-19, A Vital Value-Add
At the beginning of 2020, fear was unleashed globally as the United States government announced a public health emergenc ...
AUG 19, 2021
Immunology
Insights Into the Interplay Between COVID and the Nasal Microbiome
AUG 19, 2021
Insights Into the Interplay Between COVID and the Nasal Microbiome
There is a spectrum of COVID symptom severity: some recover after experiencing nothing more than a mild cough, while oth ...
SEP 14, 2021
Immunology
Extinguishing Fires in the Brains of MS Patients
SEP 14, 2021
Extinguishing Fires in the Brains of MS Patients
  A closer look at the brains of patients with aggressive, debilitating forms of multiple sclerosis (MS) reveals so ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
Loading Comments...